1. IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10. (11th November 2018) Authors: Steen‐Louws, C.; Hartgring, S. A. Y.; Popov‐Celeketic, J.; Lopes, A. P.; de Smet, M. B. M.; Eijkelkamp, N.; Lafeber, F. P. J. G.; Hack, C. E.; van Roon, J. A. G. Journal: Clinical and experimental immunology Issue: Volume 195:Number 1(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗